Find Grants for Non-profits

Find Out If You Qualify for Verified Grants! Discover your eligibility and access 1,903 verified grants for nonprofits, small businesses, startups, and individuals from trusted foundations and government sources.

Total Dollar Available
$ 100 Trillion

Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)

Deadline: January 7, 2028

Opportunity Number: PAR-25-291

Agency: National Institutes of Health

Open Date: November 22, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.242

View Grant

BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships (R34 - Clinical Trials Not Allowed)

Deadline: June 17, 2026

Opportunity Number: RFA-NS-25-016

Agency: National Institutes of Health

Open Date: November 21, 2024

Close Date: June 17, 2026

Status: Posted

CFDA Numbers: 93.173, 93.866, 93.273, 93.853, 93.286, 93.279, 93.867, 93.242, 93.213, 93.865

View Grant

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)

Deadline: November 17, 2026

Opportunity Number: PAR-25-274

Agency: National Institutes of Health

Open Date: November 21, 2024

Close Date: November 17, 2026

Status: Posted

CFDA Numbers: 93.213

View Grant

Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)

Deadline: May 4, 2026

Opportunity Number: PAR-25-106

Agency: National Institutes of Health

Open Date: November 21, 2024

Close Date: May 4, 2026

Status: Posted

CFDA Numbers: 93.394, 93.395

View Grant

Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)

Deadline: November 17, 2026

Opportunity Number: PAR-25-268

Agency: National Institutes of Health

Open Date: November 21, 2024

Close Date: November 17, 2026

Status: Posted

CFDA Numbers: 93.213

View Grant

NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)

Deadline: November 17, 2026

Opportunity Number: PAR-25-267

Agency: National Institutes of Health

Open Date: November 21, 2024

Close Date: November 17, 2026

Status: Posted

CFDA Numbers: 93.213

View Grant

Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)

Deadline: January 7, 2028

Opportunity Number: PAR-25-287

Agency: National Institutes of Health

Open Date: November 21, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.242

View Grant

Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)

Deadline: January 7, 2028

Opportunity Number: PAR-25-286

Agency: National Institutes of Health

Open Date: November 21, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.242

View Grant

Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)

Deadline: January 7, 2027

Opportunity Number: PAR-25-235

Agency: National Institutes of Health

Open Date: November 21, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.242, 93.879

View Grant

Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)

Deadline: May 7, 2027

Opportunity Number: PAR-26-001

Agency: National Institutes of Health

Open Date: November 21, 2024

Close Date: May 7, 2027

Status: Posted

CFDA Numbers: 93.307, 93.273, 93.399, 93.121, 93.279, 93.313

View Grant

Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)

Deadline: May 7, 2026

Opportunity Number: PAR-25-254

Agency: National Institutes of Health

Open Date: November 21, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.399

View Grant

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

Deadline: October 8, 2027

Opportunity Number: PAR-25-248

Agency: National Institutes of Health

Open Date: November 21, 2024

Close Date: October 8, 2027

Status: Posted

CFDA Numbers: 93.393

View Grant

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

Deadline: November 18, 2027

Opportunity Number: RFA-DA-26-034

Agency: National Institutes of Health

Open Date: November 20, 2024

Close Date: November 18, 2027

Status: Posted

CFDA Numbers: 93.839, 93.837, 93.840, 93.855, 93.233, 93.279, 93.838

View Grant

NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)

Deadline: October 14, 2027

Opportunity Number: PAR-25-135

Agency: National Institutes of Health

Open Date: November 20, 2024

Close Date: October 14, 2027

Status: Posted

CFDA Numbers: 93.398

View Grant

NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)

Deadline: November 19, 2026

Opportunity Number: PAR-25-052

Agency: National Institutes of Health

Open Date: November 20, 2024

Close Date: November 19, 2026

Status: Posted

CFDA Numbers: 93.853

View Grant

Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)

Deadline: September 7, 2027

Opportunity Number: PAR-25-112

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.865, 93.173

View Grant

Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)

Deadline: September 7, 2027

Opportunity Number: PAR-25-113

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.865, 93.173

View Grant

Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)

Deadline: January 7, 2028

Opportunity Number: PAR-25-243

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.393

View Grant

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

Deadline: November 16, 2027

Opportunity Number: PAR-25-244

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: November 16, 2027

Status: Posted

CFDA Numbers: 93.393

View Grant

Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)

Deadline: September 7, 2026

Opportunity Number: PAR-25-038

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242

View Grant

Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)

Deadline: September 7, 2026

Opportunity Number: PAR-25-037

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242

View Grant

Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)

Deadline: September 7, 2027

Opportunity Number: PAR-25-228

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.879, 93.172

View Grant

Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)

Deadline: September 7, 2027

Opportunity Number: PAR-25-229

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.172, 93.879

View Grant

Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)

Deadline: May 7, 2026

Opportunity Number: PAR-25-176

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.351

View Grant

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

Deadline: January 7, 2027

Opportunity Number: PAR-25-069

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.393

View Grant